boceprevir
General
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
boe-sep-re-vir
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Victrelis
Ther. Class.
Pharm. Class.
protease inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Boceprevir." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109594/2/boceprevir.
Vallerand AHA, Sanoski CAC. Boceprevir. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109594/2/boceprevir. Accessed June 29, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Boceprevir. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109594/2/boceprevir
Vallerand AHA, Sanoski CAC. Boceprevir [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 29]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109594/2/boceprevir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - boceprevir
ID - 109594
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/109594/2/boceprevir
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

